|
Post by patten1962 on Jan 25, 2016 22:56:27 GMT -5
Opinions on what the next few months will bring?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 25, 2016 22:57:01 GMT -5
.
|
|
|
Post by agedhippie on Jan 25, 2016 22:59:50 GMT -5
That was my reaction as well
|
|
|
Post by mnkdfann on Jan 25, 2016 23:02:34 GMT -5
Opinions on what the next few months will bring? Alternating bouts of disabling angst and mild euphoria.
|
|
|
Post by trondisc on Jan 26, 2016 3:41:15 GMT -5
We're screwed. Only confirmation at hints of a recovery would be in late 2017. Even if MannKind had multiple partners in 2016 those beneficial "effects" wouldn't mature until at least a year or two down the road. I'm a Long and fully admit I will probably never see my money back. I still have the sell trigger set for $2.99 if ever, LOL. I'm so f*cked.
|
|
|
Post by patten1962 on Jan 26, 2016 5:55:36 GMT -5
If you are in at $11 or $5 I would say you are in trouble. I am in at 83 cents and 66 cents. If it gets over a $1 or even back to its $1.50 $2.00 range I am happy! Not sure what the next few months will hold. I will tell you 1 of the Vanguard funds has about 5 million shares of this stock or at least they did 2 months ago.
|
|
|
Post by parrerob on Jan 26, 2016 6:28:38 GMT -5
Even if I clearly know that everything can happen here (including going BK or going to 5$ in one night) I believe nothing will happen at least till April.
Nothing will happen for me... But for lucky guys entering in the "peanuts" range it can be a different story. I believe, in fact, PPS will go up and down (or down and up) in the range 0.5$ - 1$ (till April ?) Then may be some spike upwards then probably "forced" down again
Afrezza: I am expecting very bad results from scripts till April when the product will be fully returned to us. Also no big change in prices and insurance and study as well (including other country news). Sanofi will, carefully, continue to destroy the product that clearly after April will be a concurrencial product ! They cannot say to actual doctors prescribing, that the product will be no more available in the future but thay can give the message "We will not promote it anymore" + "dubt that someone else will promote". This message will stop sure doctors prescribing for new users....
On the good side I believe our management team is working hard these days in order to start day 1 with II launch plan (real launch plan). Quite sure no communication/information till April. This will sure create enthusiasm again, but be carfeull as the way is so long (and not sure) it will be easy for basher to damage MNKD credibility in the market as done since years....
TS: I like so much the actual partnership deal. No money (immediate) but no risks too and sure no costs. Also this way could solve or bypass the "cartel" problem. And in the long run it is very very promising ! Open Source technology ! But again it is a long road !
So answering to Your question: If You invested, like me, since years in this stock it is better You take a decision now. Decide how many shares You want to keep (from 0 to all) and stop looking at daily PPS at least for 1-2 years. If You invested recently, may be You can wait the first spike and sell making a good gain. If You are a trader (not my case) and You like to buy and sell here I believe there are big margins to make big gains (But be carefull You are going to play with sharks).
|
|
|
Post by mindovermatter on Jan 26, 2016 6:29:14 GMT -5
If you are in at $11 or $5 I would say you are in trouble. I am in at 83 cents and 66 cents. If it gets over a $1 or even back to its $1.50 $2.00 range I am happy! Not sure what the next few months will hold. I will tell you 1 of the Vanguard funds has about 5 million shares of this stock or at least they did 2 months ago. I am not suggesting that this will happen anytime soon, but good news can do wonders to push a stock up. Remove the vast swirling winds of uncertainty around Mannkind and the share price will rebound. As to what exactly will do that, who knows. But if the robber barons on Wall Street change their sentiment to positive, watch out. Mannkind will fly. And to be clear, I am not saying this is going to happen but I've seen it with other in the dumpster biotech stocks.
|
|
|
Post by parrerob on Jan 26, 2016 6:41:34 GMT -5
I was convinced that Afrezza could validate the all TS platform ..... Now I hope the TS platform will sustain Afrezza till his success !
Hope is not a good word... But after what happened since I am following MannKind "Hope" is the only word I can use today.
The dark side of wall street was right and succesfull. They took away any certainty. Message they send us are clear (just take a look at closure yesterday or 2 day before) The message is "We can do what we want with this stock"
Personally I loose a battle (in fact I am no more buying) but I prefer to loose the whole investment (I will sell when All sell) but to stay with the "right" side for the final war.
|
|
|
Post by matt on Jan 26, 2016 9:36:15 GMT -5
I expect that script numbers will slowly decay until April. Salesmen focus their energy on products that will add to their bonus and since the whole world knows that SNY will not have the drug as of April, don't expect anything very helpful from SNY. What happens after that depends on what MNKD comes up with; I don't know that a social media strategy will get the job done as that is not how physicians are used to learning about drugs. We will just have to wait and see.
What will really be telling is the expense load MNKD will have to incur. Not only will the SNY loan facility be gone, which was funded MNKD's 35% of partnership losses, but MNKD will also have to eat the 65% SNY was paying for out of their pocket. I am sure MNKD is looking to shave every last penny off the budget when SNY leaves, but they can't shave it to $0. The first time we will get a good lock at those numbers will be mid-August when the 10-Q for the second quarter will get published. That will be the first hard look at both sales performance and expense burden in the post-Sanofi environment. It will also be the first time shareholders get to see, in detail, what the cash flow looks like.
When the second quarter 10-Q hits, the stock price will likely move big time, although it is hard to predict whether that movement will be up or down. If faced with a big movement of uncertain direction, owning options on either side of the argument is the winning trade.
|
|
|
Post by suebeeee1 on Jan 26, 2016 9:52:08 GMT -5
When we discover that this magical, invisible partner for our Technosphere platform has deep pockets, the share price will shoot back over $1. Time- before April. Then, dtc ads start for Afrezza, and we are off to the races.
|
|
|
Post by 4allthemarbles on Jan 26, 2016 11:28:13 GMT -5
This might be slightly off topic, but to help put things in perspective- Social Media has gotten world leaders elected. The old guard always underestimates it.
As far as the stock price goes- if you believe in it- buy it. There will still be volatile until, at the VERY MINIMUM, April.
No one, including your self, can be faulted for not buying more. If you aren't sure, wait a bit- the stock is going to be down for a bit.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 26, 2016 11:32:09 GMT -5
This might be slightly off topic, but to help put things in perspective- Social Media has gotten world leaders elected. The old guard always underestimates it. As far as the stock price goes- if you believe in it- buy it. There will still be volatile until, at the VERY MINIMUM, April. No one, including your self, can be faulted for not buying more. If you aren't sure, wait a bit- the stock is going to be down for a bit. But Afrezza hasnt picked up cos of social media cos only people who understand Afrezza knows its benefits and most of the people are dumb too with no motivation
|
|
|
Post by 4allthemarbles on Jan 26, 2016 11:38:03 GMT -5
This might be slightly off topic, but to help put things in perspective- Social Media has gotten world leaders elected. The old guard always underestimates it. As far as the stock price goes- if you believe in it- buy it. There will still be volatile until, at the VERY MINIMUM, April. No one, including your self, can be faulted for not buying more. If you aren't sure, wait a bit- the stock is going to be down for a bit. But Afrezza hasnt picked up cos of social media cos only people who understand Afrezza knows its benefits and most of the people are dumb too with no motivation It's a start. Keep in mind, people that were using social media for Affrezza aren't always experts with grass roots movements (sure, some of them are, but not all). That said, a concentrated effort could lead to other things- not a guarantee, mind you. But we now have a mysterious new partner- do you think SNY got that for us? Only time will tell- but I don't think we are sunk yet. Just my opinion. I bought more when we were around .67 or so. GLTA
|
|
|
Post by gamblerjag on Jan 26, 2016 11:47:12 GMT -5
Sorry to post this here on this thread.. not seeing reply button on delisting. Suebee.. I absolutely think MNKD will be over 1 buck way before one year. probably in the next 2 weeks.. (guess).. to the other poster. .Absolutely MNKD would get an extension. IVAN got extension twice before it went BK.. and they had no sales, and was barely a company.. so yes Nasdaq would absolutely give the extension of needed .. it won't be needed.
|
|